Table 1 Cost utility and cost effectiveness analyses at 14 days and 3 months (Complete case analysis)
n | £ | Outcome | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
A | P | A | P | Increment (95% CI) | A | P | Increment (95% CI) | ICER | P(ICER ≤ £30k)** | |
1. 14d survival* | 112 | 59 | 2553 | 2525 | 28 (-228, 269) § | 0.955 | 0.898 | 0.057 (-0.028, 0.144) | £490 | |
2. 14d D&D† | 112 | 59 | 2553 | 2525 | 28 (-215, 278) § | 0.393 | 0.407 | -0.014 (-0.169, 0.149) | [P dominant] | |
3. 14d CUA‡ | 112 | 59 | 2553 | 2525 | 28 (-226, 268) § | 0.028 | 0.027 | 0 (-0.001, 0.002) | £76,162 | 45.9% |
4. 3 m survival* | 105 | 57 | 8234 | 9233 | -1000 (-3760, 1588) | 0.905 | 0.789 | 0.115 (0.001, 0.232) | [A dominant] | |
5. 3 m D&D† | 17 | 14 | 5324 | 10835 | -5511 (-15183, 1221) | 0.412 | 0.071 | 0.340 (0.080, 0.588) | [A dominant] | |
6. 3 m CUA‡ | 17 | 14 | 5324 | 10835 | -5511 (-15712, 1311) | 0.098 | 0.054 | 0.044 (0.000, 0.086) | [A dominant] | 96.5% |